AGT-182-101: A Phase 1 Safety and Dose-Finding Study of a Human Insulin Receptor Monoclonal Antibody-Human Iduronate 2-Sulfatase (IDS) Fusion Protein, AGT-182 in Adult Patients with Mucopolysaccharidosis II (MPS II, Hunter Syn
- Burton, Barbara K (PD/PI)
- Alden, Tord D (Co-Investigator)
- Charrow, Joel (Co-Investigator)
- Epstein, Leon G (Co-Investigator)
Project: Research project